Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Randomized Multicenter Comparative Trial Of 5 Years Adjuvant Exemestane Treatment Versus 5 Years Adjuvant Tamoxifen Treatment In Postmenopausal Women With Early Breast Cancer

NCT00032136 is registered in ClinicalTrials.gov with Cancer Research Campaign Clinical Trials Centre as lead sponsor.

NCT NCT00032136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00032136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Randomized Multicenter Comparative Trial Of 5 Years Adjuvant Exemestane Treatment Versus 5 Years Adjuvant Tamoxifen Treatment In Postmenopausal Women With Early Breast Cancer
Lead sponsor
Cancer Research Campaign Clinical Trials Centre
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2001
Completion date
April 30, 2009
Enrollment
4,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer